Aadi Bioscience, Inc.
AADINASDAQHealthcare
$2.05
$-0.05(-2.38%)
Market Cap$94891630
P/E Ratio—
52W High$3.812
52W Low$1.21
Aadi Bioscience, Inc.（AADI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AADI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.14M | $25.98M | $24.35M | $15.22M | $1.12M |
| Cost of Revenue | $0.00M | $3.02M | $2.81M | $1.33M | $0.28M |
| Gross Profit | $0.00M | $22.96M | $21.55M | $13.88M | ($18.55M) |
| Gross Margin %(computed) | 0.00% | 88.36% | 88.47% | 91.23% | — |
| Operating Expenses | |||||
| R&D Expenses | $90.96M | $51.03M | $48.93M | $32.66M | $19.67M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $18.51M |
| Total Operating Expenses | $121.55M | $90.42M | $93.48M | $72.84M | $92.67M |
| Operating Income | ($114.40M) | ($67.46M) | ($71.93M) | ($58.96M) | ($111.22M) |
| Operating Margin %(computed) | — | -259.62% | -295.36% | -387.47% | — |
| Interest Income | $6.23M | $3.92M | $6.40M | $2.40M | $0.01M |
| Interest Expense | $0.00M | $0.15M | $0.23M | $0.23M | $0.67M |
| Income Before Tax | ($20.60M) | ($63.69M) | ($65.77M) | ($60.51M) | ($110.09M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($20.60M) | ($63.69M) | ($65.77M) | ($60.51M) | ($110.09M) |
| Net Margin %(computed) | -288.26% | -245.13% | -270.04% | -397.69% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| Wtd Avg Shares | 618.87M | 26.99M | 26.92M | 22.51M | 8.92M |
| EBITDA | ($114.40M) | ($64.63M) | ($65.36M) | ($60.12M) | ($109.15M) |
| EBITDA Margin %(computed) | — | -248.72% | -268.40% | -395.14% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Aadi Bioscience, Inc.
关于Aadi Bioscience, Inc.（AADI）损益表
Aadi Bioscience, Inc.（AADI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AADI实现营收$0.01B，毛利润$0.00B（毛利率0.00%），净利润($0.02B)（净利率-288.26%）。
常见问题
AADI · 4 问Aadi Bioscience, Inc.（AADI）2025财年营收为$0.01B，同比down72.5%。
AADI revenueAADI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09